Stay updated on Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial

Sign up to get notified when there's something new on the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page’s footer version/revision label has been updated from 3.5.2 to 3.5.3, reflecting a maintenance/release update with no apparent change to the study’s recorded information.
    Difference
    0.1%
    Check dated 2026-04-24T05:42:38.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Added a new revision entry (v3.5.2) and removed an older revision (v3.5.0) in the study record history; this is a metadata version update rather than a change to the study data.
    Difference
    0.1%
    Check dated 2026-04-17T02:25:09.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed on the Record History page, indicating a software update to the history tracking system.
    Difference
    0.1%
    Check dated 2026-03-19T05:12:47.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 to the history and removed Revision: v3.4.2 from the history.
    Difference
    0.1%
    Check dated 2026-03-11T23:37:01.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The history now includes an added Revision: v3.4.2 and the previous funding-status notice was removed, with no changes to the actual study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T10:59:24.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Added a government funding status notice and updated the page revision to v3.4.1, replacing v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-04T10:25:15.000Z thumbnail image

Stay in the know with updates to Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page.